MuPharma is a business based in Victoria, Australia that has developed various novel, ultrasound based, non-invasive devices to deliver drugs to the body that would ordinarily require injections or other highly invasive delivery means. Principal sites of application include the eye (anterior and posterior segment) and the inside of the mouth.
Murdoch University in Perth, Australia, have more than 22,000 students and 2,000 staff from across 90 different countries.
My Emergency Dr is an Australian-owned and operated 24/7 tele-emergency service that instantly puts patients, carers and clinicians in touch with a specialist emergency physician via a freely downloadable videoconferencing app.
My Sport Evolution represents Hexoskin in Australia, the only clinically validated wearable system that allows ECG cardiac monitoring with lung function and activity tracking. Hexoskin is a cost-effective and non-invasive solution for long-term (remote) patient observation & data collection.
MyOnlineClinic is the only integrative cloud based Health Tech platform that enables all Healthcare providers connectivity as a PMS (practice management software) through Telehealth using mobile technology, connected to bluetooth enabled medical devices and wearables best environment to diagnose and manage health.
NanoMed Pty Ltd is a nanobiotech company based in Sydney, Australia. Our mission is to design, develop and commercialise colloidal nanomedicines for use as cancer therapeutics and diagnostic imaging agents.
NCI is the leading national institution for high performance computing, and provides world-class high-end services to more than 4,000 Australian researchers from 31 universities, five science agencies and several medical research institutes.
The National Health and Medical Research Council (NHMRC) is Australia’s leading expert body promoting the development and maintenance of public and individual health standards.
NextMed Capital's mission is to nurture the seeds of the next generation of medical innovation. The company was founded in 2016 with the goal of becoming Australia's leading very early stage innovation and medical technology investor. NextMed Capital can invest in projects as early as the pre-clinical phase and adds significant value to its investments through leveraging the combined commercial, entrepreneurial, project management, financing, business planning and academic skills of its experienced management team.
Formed in October 2013, NIESM is a Melbourne-based Australian company that delivers clinician support tools focused around wearable technologies and an enterprise software platform to provide optimal health outcomes for patients with epilepsy. NIESM has put together a global team with world leaders in technology, clinical and business capabilities and they are committed to helping patients become seizure free.
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies.
Novita Healthcare is an emerging health sector technology company encompassing the current businesses of TALI Health and Newly. The TALI system uses proprietary software algorithms to monitor and assist in the treatment of cognitive problems such as attention difficulties in early childhood.
Nucleus Network is a leading early phase clinical research organisation in Australia, providing an expedited regulatory pathway, the CTN scheme, for the initiation of first-in-human clinical trials without the need for filing an IND.
As a small start-up company, born of the digital age, OMX-Solutions have the flexibility of providing custom devices, which can easily and rapidly be delivered through the use of CAD-CAM technology. With our experience in digital design, and our successful use of devices developed by advanced additive and subtractive manufacturing methods, we have the capability of producing an unlimited range of medical devices that is only limited by our imagination.
The Oral Health CRC seeks to reduce the economic and social burden of oral diseases on Australians. They bring together world-class scientific and clinical research teams with Australian manufacturers and established global marketers and distributors.
Orthocell is a regenerative medicine company focused on regenerating mobility for patients by developing products for the repair of a variety of tendon, cartilage and soft tissue injuries.
Osteon Medical is an Australian-owned company that designs and manufactures a specialised range of dental and facial implant prosthetic products. All products are digitally created and precision milled for dental and Maxillofacial professionals. Osteon's implant frameworks are designed specific to each patient with the aim to restore or replace the function of patient bone, teeth or soft tissues in affected areas, restore normal function and resemble natural aesthetics.
Pacific Analytics are an analytics company building analysis tools, databases pipelines and software specialising in precision medicine. Its current clients include the Cerebral Palsy Research Foundation and Iggy Get out! a motor neurone disease research non-profit organisation.
With over 20 years’ experience in Australia's & New Zealand's Medical Devices and Biotech industries, Paul L Clark and Associates offers an expansive range of Regulatory, Clinical, Quality Management & Commercial services for medical device companies marketing their products. They cover the Australian Register of Therapeutic Goods (ARTG); sponsorship for international companies selling into Australia; liaison with the Therapeutic Goods Administration (TGA); and commercial services.